Pulmonary Metastatic Osteosarcoma (pOS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Pulmonary Metastatic Osteosarcoma (pOS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 1/2

NCT03811886

Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic Osteosarcoma

The purpose of this study is to evaluate the safety and tolerability of Natalizumab in children, adolescent and young adult patients with pulmonary metastatic o…

United States0Started 2024-12-01

Treatment: Natalizumab